LCGC Europe and HTC-17 Launch 2022 HTC Innovation Award
LCGC Europe, a leading multimedia platform of peer‐reviewed technical information in the field of chromatography and the separation sciences, is now accepting nominations for the 2022 HTC Innovation Award through to June 30, 2021.
The 2022 HTC Innovation Award winner will be selected by the HTC‐17 Scientific Committee and the HTC‐17 Industry Board, based on the following criteria:
- The winner has made a pioneering contribution to the field of separation sciences by introducing new methodologies, new instrumentation, or new techniques in the field, with a strong focus on applicability.
- Applications are open to scientists who have under 15 years of experience after completing their PhD.
- Applications from separation scientists worldwide are welcomed. LCGC Europe readers can nominate themselves or others.
The 2022 HTC Innovation Award recipient will be presented with a plaque honouring their accomplishment at the HTC‐17 conference, which will be held in Ghent, Belgium, at Het Pand, the culture and congress center of Ghent University, Jan. 26–28, 2022.
For more information and to submit a nomination, click here: https://bit.ly/3wcb3dW
AOAC International Awarded NIST Grant for Developing Drug Testing Standards
October 31st 2024The grant will be part of a new collaborative scientific initiative to address the need for standards that define the desired performance of lateral flow immunoassay test strips to detect illicit drugs in tablets and powders.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
